Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

A, Woolloongabba N Clinical Trials

A listing of A, Woolloongabba N clinical trials actively recruiting patients volunteers.

RESULTS

Found (53) clinical trials

This is an evaluator-blind study of the safety and performance of fractional radiofrequency for the treatment and reduction of acne scarring.  All enrolled subjects will receive 3 treatments to the face, with 3-5 week intervals between treatments. There are 6 in-office visits throughout the study and can include a physical ...

Phase

This is an evaluator-blind study of the safety and performance of fractional radiofrequency for the treatment and reduction of facial wrinkles.  All enrolled subjects will receive 3 treatments to the face, with 3-5 week intervals between treatments. There are 6 in-office visits throughout the study and can include a small ...

Phase

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).  

Phase

A 52 Week, Multicenter Study To Assess The Time Course Of Response To Secukinumab On Joint Inflammation Using Power Doppler Ultrasonography In Patients With Active Psoriatic Arthritis.  

Phase

A Randomized, Double-Blind, Study Comparing ABT-494 To Placebo And To Humira In Subjects With Active Psoriatic Arthritis That Has/Had A History Of Inadequate Response To At Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD).  

Phase

A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)  

Phase

If you are age 18 or over and are an experienced soft contact lens wearer and you have been told by your doctor that you have astigmatism, you may be eligible to participate in a clinical trial. Please call Oculus Research at 919-346-6945 for more information. ClinicalTrials.gov Identifier: NCT03681808  

Phase N/A

  Please note we are currently recruiting for general screening only with a compensation of $50 Should you qualify, please see study details below: Compensation: Up to $5,800 upon study completion General Screening Dates: 07-Jan, 11-Jan, 14-Jan, 18-Jan Study duration: 3 cohorts (based on clinic assignment)  

Phase N/A

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a board-certified dermatologist at no cost.  

Phase N/A